Showing 1 - 10 of 1,474
Government-financed health care (GFHC) expenditures, through Medicare and Medicaid, have grown from roughly zero to over 7.6 percent of national personal income over the past 50 years. Recently, some analysts (e.g., the Council of Economics Advisers (2014)) have argued that an expansion of GFHC...
Persistent link: https://www.econbiz.de/10011782606
Child maltreatment is a major public health problem with significant consequences for individual victims and for society. In this paper we quantify for the first time the economic costs of fatal and non-fatal child maltreatment in the UK in relation to several short-, medium- and long-term...
Persistent link: https://www.econbiz.de/10012599721
Persistent link: https://www.econbiz.de/10014470444
Persistent link: https://www.econbiz.de/10012306887
Persistent link: https://www.econbiz.de/10011785880
"We examine the effect of exposure to toxic releases that are tracked by the Toxic Release Inventory (TRI) on county-level infant and fetal mortality rates in the United States between 1989-2002. We find significant adverse effects of TRI concentrations on infant mortality rates, but not on...
Persistent link: https://www.econbiz.de/10003831831
In this paper, we address the issue of spurious correlation in the production of health in a systematic way. Spurious correlation entails the risk of linking health status to medical (and nonmedical) inputs when no links exist. This note first presents the bounds testing procedure as a method to...
Persistent link: https://www.econbiz.de/10003900852
The paper studies the incentive for providers to invest in new health care technologies under alternative payment systems, when the patients' benefits are uncertain. If the reimbursement by the purchaser includes both a variable (per patient) and a lump-sum component, efficiency can be ensured...
Persistent link: https://www.econbiz.de/10008746927
Persistent link: https://www.econbiz.de/10012505689
Persistent link: https://www.econbiz.de/10011898853